Neladalkib

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameNeladalkib
Drug Alias NameJ32P26A6BCNUV-655NVL-655
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnaplastic lymphoma kinase inhibitors
TargetsAnaplastic lymphoma kinase
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[29] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesNuvalent Inc
China Registration ClassN/A

Develop Information

Active CompaniesNuvalent Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A